Tokyo, June 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061808) titled 'Study on biomarkers in saliva' on June 8.
Study Type:
Observational
Primary Sponsor:
Institute - Macromill, Inc.
Condition:
Condition - Healthy participants
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To explore biomarkers in saliva that enable visualization of health status.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Individuals within a specific age range (20 to 89 years old) who do not fall under the exclusion criteria.
Key exclusion criteria - 1. Individuals with serious chronic diseases.
2. History of anemia, kidney disease, cerebrovascular disorder, cancer, chronic inflammation, or mental illness.
3. History of bariatric surgery or liposuction.
4. Major surgery or hospitalization within 6 months before the start of the study.
5. Pregnant or lactating women.
6. History of substance abuse.
7. Diagnosis of serious mental illness or dementia.
8. Current serious infectious diseases (HIV, hepatitis virus infection, etc.).
9. Habit of chronic alcohol consumption (alcoholism).
10. Individuals judged inappropriate as subjects based on the background questionnaire.
11. Individuals requiring nursing care certification.
12. Individuals with a daily smoking habit.
13. Diagnosis of abnormal oral environment (periodontal disease, etc.)
Target Size - 300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 22 Day
Anticipated trial start date - 2026 Year 06 Month 08 Day
Last follow-up date - 2026 Year 08 Month 14 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070730
Disclaimer: Curated by HT Syndication.
